Supplementary figure legends
Table S1. Features of the MDS patients included in this study. Table  S2 . Primers used in this study. Figure S1 . Complementary results obtained in K562 and UT---7 cells upon inducible expression of SF3B1 K700E or upon transitory expression of other important SF3B1 variants. (A) ---Detection of SF3B1 proteins in K562 cells following inducible expression of SF3B1 WT or SF3B1 K700E . The immunoblot shows three independent K562 cell populations expressing SF3B1 WT (left) or SF3B1 K700E (right) (I: induced, NI: non---induced). (B) Detection of SF3B1 proteins in K562 expressing distinct SF3B1 variants. K562 cells were transiently transfected by plasmids expressing SF3B1 WT , SF3B1 K700E , SF3B1 E622D , SF3B1 H662Q and SF3B1 K666E . (C) Detection of SF3B1 proteins in UT---7 cells following inducible expression of SF3B1 WT or SF3B1 K700E . The immunoblot shows two independent UT---7 cell populations expressing SF3B1 WT (left) or SF3B1 K700E (right) (I: induced, NI: non---induced). In (A---C), total SF3B1 proteins (endogenous and exogenous) were detected using anti---SF3B1 antibody. Plasmid---encoded SF3B1 was detected using anti---FLAG antibody.
Figure S2
. SF3B1insFLAG proteins are correctly addressed to the nucleus. Immunofluorescence staining of SF3B1---FLAG proteins in inducible K562 cell lines expressing various SF3B1 constructs. Nuclei were stained with DAPI. Figure S3 . Splicing analysis of RBM5, DUSP11, CCNA2 and STK6 in inducible K562 cell lines expressing shSF3B1 alone or in combination with various SF3B1 constructs. (A) Analysis of splicing events known to be specifically altered upon SF3B1 loss of function (RBM5, DUSP11) or SF3B1 mut background (ENOSF1, TMEM14C, DPH5). (B) Quantification of CCNA2 or STK6 exon skipping was done by RT---qPCR, using primers allowing specific quantification of exon skipping events in CCNA2 (exon 5) and STK6 (exons 4, 5 and 6) transcripts, normalized to GAPDH. Figure S4 . Expression of the main disease---related SF3B1 mutations does not affect growth of the Schizosaccharomyces pombe prp10---1 strain. (A) Multiple alignment of the predominantly affected SF3B1 protein region in MDS (ClustalW software). The mouse (MOUSE), human (HUMAN), Schizosaccharomyces pombe (SCHPO) and Saccharomyces cerevisiae (YEAST) sequences are presented. The amino acids substitutions E622, R625, K666 and K700 found specifically in myelodysplastic syndromes are indicated in color. The lysine K700 residue, the most commonly affected in MDS, is preserved in S. pombe but not in S. cerevisiae. (B) prp10---1 mutant cells were transformed with the empty vector pREP41, or a pREP41---HA expressing the wild type or mutated alleles of SpSAP155, namely the counterparts of E622N, H662Q, K666N (R666N) and K700E. Streaks from independent transformants were made on EMM 2% glucose, replica---plated on EMM 2% glucose and cultured at 26°C or 37°C. (C) RT---PCR splicing analysis of TFIID and RPL7 transcripts in the prp10---1 strain expressing different versions of SpSAP155. Transformants were cultured at 26°C and subjected to a temperature switch at 37°C for 2 hours. RNA was extracted and analyzed by RT---PCR using specific primers allowing the detection of both spliced and un---spliced mRNA. 37 KDa 25 KDa 0,1 2,8 0,05 2,2 0,3 3,2 0,2 2,6 0,2 1,4 0 1,8 1,7 1,0 1,3 2,9 2,7 2,3 1,2 1,1 0,8 2,1 1,5 1,3 0 0 2,3 2,7 1,5 0,3 0,3 1,7 2,0 2,1 2,4 2,8 1,2 1,2 C 0,2 2,6 0,2 3,3 0,2 5,2 0,1 4 1,3 1,2 1,2 1,1 0,7 0,9 1,1 1,8 
